Opzelura is the first and only FDA-approved treatment for repigmentation in patients with vitiligo, and the only topical formulation of a Janus kinase inhibitor approved in the United States.
The retailer provided a business update revising its profit outlook for the second quarter and full fiscal year, primarily due to pricing actions aimed at improving inventory levels at Walmart and Sam’s Club.